Differential effects of Francisella tularensis lipopolysaccharide on B lymphocytes

Journal of Leukocyte Biology

Volumn 82, Issue 4, 2007, Pages 813-820

  Rahhal, Riad M ^a   Vanden Bush, Tony J ^b   McLendon, Molly K ^b   Apicella, Michael A ^b   Bishop, Gail A ^a,b,c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

B cell immunology; Bacterial components; Human; Tularemia

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL INTERACTION; CELL TYPE; CONTROLLED STUDY; CYTOKINE RELEASE; FRANCISELLA TULARENSIS; HUMAN; HUMAN CELL; MACROPHAGE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPECIES DIFFERENCE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODY FORMATION; B-LYMPHOCYTES; BIOLOGICAL WARFARE; CELL LINE; FRANCISELLA TULARENSIS; HUMANS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MACROPHAGES; MICE; MODELS, IMMUNOLOGICAL; SPECIES SPECIFICITY; TUMOR NECROSIS FACTOR-ALPHA; VACCINES, SUBUNIT;

ANIMALIA; BACTERIA (MICROORGANISMS); FRANCISELLA TULARENSIS;

EID: 34848826513     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1206765     Document Type: Article

References (41)

1. Khan, A. S., Morse, S., Lillibridge, S. (2000) Public-health preparedness for biological terrorism in the USA. Lancet 356, 1179-1182.
2. Rotz, L. D., Khan, A. S., Lillibridge, S. R., Ostroff, S. M., Hughes, J. M. (2002) Public health assessment of potential biological terrorism agents. Emerg. Infect. Dis. 8, 225-230.
3. Dennis, D. T., Inglesby, T. V., Henderson, D. A., Bartlett, J. G., Ascher, M. S., Eitzen, E., Fine, A. D., Friedlander, A. M., Hauer, J., Layton, M., Lillibridge, S. R., McDade, J. E., Osterholm, M. T., O'Toole, T., Parker, G., Perl, T. M., Russell, P. K., Tonat, K. (2001) Tularemia as a biological weapon: medical and public health management. JAMA 285, 2763-2773.
4. Sjostedt, A. (2003) Virulence determinants and protective antigens of Francisella tularensis. Curr. Opin. Microbiol. 6, 66-71.
5. Elkins, K. L., Cowley, S. C., Bosio, C. M. (2003) Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain. Microbes Infect. 5, 135-142.
6. Sandstrom, G. (1994) The tularaemia vaccine. J. Chem. Technol. Biotechnol. 59, 315-320.
7. Tarnvik, A. (1989) Nature of protective immunity to Francisella tularensis. Rev. Infect. Dis. 11, 440-451.
8. Burke, D. S. (1977) Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia. J. Infect. Dis. 135, 55-60.
9. Culkin, S. J., Rhinehart-Jones, T., Elkins, K. L. (1997) A novel role for B cells in early protective immunity to an intracellular pathogen, Francisella tularensis strain LVS. J. Immunol. 158, 3277-3284.
10. Elkins, K. L., Rhinehart-Jones, T., Nacy, C. A., Winegar, R. K., Fortier, A. H. (1993) T-cell-independent resistance to infection and generation of immunity to Francisella tularensis. Infect. Immun. 61, 823-829.
11. Telepnev, M., Golovliov, I., Grundstrom, T., Tarnvik, A., Sjostedt, A. (2003) Francisella tularensis inhibits Toll-like receptor-mediated activation of intracellular signaling and secretion of TNF-α and IL-1 from murine macrophages. Cell. Microbiol. 5, 41-51.
12. Cole, L. E., Elkins, K. L., Michalek, S. M., Qureshi, N., Eaton, L. J., Rallabhandi, P., Cuesta, N., Vogel, S. N. (2006) Immunologic consequences of Francisella tularensis live vaccine strain infection: role of the innate immune response in infection and immunity. J. Immunol. 176, 6888-6899.
13. Phillips, N. J., Schilling, B., McLendon, M. K., Apicella, M. A., Gibson, B. W. (2004) Novel modification of lipid A of Francisella tularensis. Infect. Immun. 72, 5340-5348.
14. Hajjar, A. M., Harvey, M. D., Shaffer, S. A., Goodlett, D. R., Sjostedt, A., Edebro, H., Forsman, M., Bystrom, M., Pelletier, M., Wilson, C. B., Miller, S. I., Skerrett, S. J., Ernst, R. K. (2006) Lack of in vitro and in vivo recognition of Francisella tularensis subspecies lipopolysaccharide by Toll-like receptors. Infect. Immun. 74, 6730-6738.
15. Dreisbach, V. C., Cowley, S., Elkins, K. L. (2000) Purified lipopolysaccharide from Francisella tularensis live vaccine strain (LVS) induces protective immunity against LVS infection that requires B cells and γ interferon. Infect. Immun. 68, 1988-1996.
16. Gantt, K. R., Goldman, T. L., McCormick, M. L., Miller, M. A., Jeronimo, S. M., Nascimento, E. T., Britigan, B. E., Wilson, M. E. (2001) Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi. J. Immunol. 167, 893-901.
17. Bishop, G. A., Ramirez, L. M., Waldschmidt, T. J. (1994) Differential responses to Ig and class II-mediated signals in splenic B cell subsets from normal and autoimmune mice. Int. Immunol. 6, 1049-1059.
18. + B cells by clonal T cells and antigen. Proc. Natl. Acad. Sci. USA 83, 7410-7414.
19. Hirschfeld, M., Ma, Y., Weis, J. H., Vogel, S. N., Weis, J. J. (2000) Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2. J. Immunol. 165, 618-622.
20. Tomai, M. A., Gibson, S. J., Imbertson, L. M., Miller, R. L., Myhre, P. E., Reiter, M. J., Wagner, T. L., Tamulinas, C. B., Beaurline, J. M., Gerster, J. F., et al. (1995) Immunomodulating and antiviral activities of the imidazoquinoline S-28463. Antiviral Res. 28, 253-264.
21. Munroe, M. E., Bishop, G. A. (2004) Role of TRAF2 in distinct and overlapping CD40 and TNF receptor 2/CD120b-mediated B lymphocyte activation. J. Biol. Chem. 279, 53222-53231.
22. Hostager, B. S., Bishop, G. A. (2002) Role of TRAF2 in the activation of IgM secretion by CD40 and CD120b. J. Immunol. 168, 3318-3322.
23. Bishop, G. A. (1991) Requirements of class II-mediated B cell differentiation for class II cross-linking and cyclic AMP. J. Immunol. 147, 1107-1114.
24. Fortier, A. H., Green, S. J., Polsinelli, T., Jones, T. R., Crawford, R. M., Leiby, D. A., Elkins, K. L., Meltzer, M. S., Nacy, C. A. (1994) Life and death of an intracellular pathogen: Francisella tularensis and the macrophage. Immunol. Ser. 60, 349-361.
25. Fortier, A. H., Polsinelli, T., Green, S. J., Nacy, C. A. (1992) Activation of macrophages for destruction of Francisella tularensis: identification of cytokines, effector cells, and effector molecules. Infect. Immun. 60, 817-825.
26. Sandstrom, G., Sjostedt, A., Johansson, T., Kuoppa, K., Williams, J. C. (1992) Immunogenicity and toxicity of lipopolysaccharide from Francisella tularensis LVS. FEMS Microbiol. Immunol. 5, 201-210.
27. Ancuta, P., Pedron, T., Girard, R., Sandstrom, G., Chaby, R. (1996) Inability of the Francisella tularensis lipopolysaccharide to mimic or to antagonize the induction of cell activation by endotoxins. Infect. Immun. 64, 2041-2046.
28. Venkataraman, C., Shankar, G., Sen, G., Bondada, S. (1999) Bacterial lipopolysaccharide induced B cell activation is mediated via a phosphatidylinositol 3-kinase dependent signaling pathway. Immunol. Lett. 69, 233-238.
29. Mestas, J., Hughes, C. C. (2004) Of mice and not men: differences between mouse and human immunology. J. Immunol. 172, 2731-2738.
30. Abed, N. S., Chace, J. H., Fleming, A. L., Cowdery, J. S. (1994) Interferon-γ regulation of B lymphocyte differentiation: activation of B cells is a prerequisite for IFN-γ-mediated inhibition of B cell differentiation. Cell. Immunol. 153, 356-366.
31. Anderson, S. J., Lawton, A. R. (1987) LPS augments human B-cell differentiation by direct stimulation of PWM-responsive B cells. Clin. Immunol. Immunopathol. 44, 259-271.
32. Elkins, K. L., Bosio, C. M., Rhinehart-Jones, T. R. (1999) Importance of B cells, but not specific antibodies, in primary and secondary protective immunity to the intracellular bacterium Francisella tularensis live vaccine strain. Infect. Immun. 67, 6002-6007.
33. Bosio, C. M., Elkins, K. L. (2001) Susceptibility to secondary Francisella tularensis live vaccine strain infection in B-cell-deficient mice is associated with neutrophilia but not with defects in specific T-cell-mediated immunity. Infect. Immun. 69, 194-203.
34. Anthony, L. S., Kongshavn, P. A. (1987) Experimental murine tularemia caused by Francisella tularensis, live vaccine strain: a model of acquired cellular resistance. Microb. Pathog. 2, 3-14.
35. Fortier, A. H., Slayter, M. V., Ziemba, R., Meltzer, M. S., Nacy, C. A. (1991) Live vaccine strain of Francisella tularensis: infection and immunity in mice. Infect. Immun. 59, 2922-2928.
36. Roberts, T. L., Sweet, M. J., Hume, D. A., Stacey, K. J. (2005) Cutting edge: species-specific TLR9-mediated recognition of CpG and non-CpG phosphorothioate-modified oligonucleotides. J. Immunol. 174, 605-608.
37. Jurk, M., Heil, F., Vollmer, J., Schetter, C., Krieg, A. M., Wagner, H., Lipford, G., Bauer, S. (2002) Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat. Immunol. 3, 499.
38. Miyake, K., Yamashita, Y., Ogata, M., Sudo, T., Kimoto, M. (1995) RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family. J. Immunol. 154, 3333-3340.
39. Ogata, H., Su, I., Miyake, K., Nagai, Y., Akashi, S., Mecklenbrauker, I., Rajewsky, K., Kimoto, M., Tarakhovsky, A. (2000) The Toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells. J. Exp. Med. 192, 23-29.
40. Vinogradov, E., Perry, M. B., Conlan, J. W. (2002) Structural analysis of Francisella tularensis lipopolysaccharide. Eur. J. Biochem. 269, 6112-6118.
41. Rietschel, E. T., Kirikae, T., Schade, F. U., Mamat, U., Schmidt, G., Loppnow, H., Ulmer, A. J., Zahringer, U., Seydel, U., Di Padova, F., et al. (1994) Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 8, 217-225.